Delivery Order SPE2DB25D3008-SPE2DB25FRDJM
- Not listed
- The Defense Logistics Agency awarded a $25,890.84 delivery order to AmerisourceBergen Drug Corp for 60 capsules of Ofev 100 mg, a pharmaceutical product used in the treatment of pulmonary fibrosis. This firm fixed price contract was competitively awarded without a set-aside designation and is scheduled for completion by October 14, 2025. The award was announced on September 22, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $17,220.86 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Ofev 100 mg capsules (60-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 23, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $8,630.28 to AmerisourceBergen Drug Corp for 60-count bottles of Ofev 100 mg capsules, a pharmaceutical product used in the treatment of idiopathic pulmonary fibrosis. The contract, awarded on September 3, 2025, with an ultimate completion date of September 24, 2025, utilizes firm fixed pricing and represents a non-competitive set-aside delivery order. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $17,260.58 to AmerisourceBergen Drug Corp for the supply of OFEV 100 mg capsules (60-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 2, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order under its existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product being...
- The Defense Logistics Agency awarded a delivery order valued at $17,260.58 to AmerisourceBergen Drug Corp for 60-count bottles of Ofev 100 mg capsules, a pharmaceutical product used in the treatment of certain pulmonary conditions. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by October 14, 2025. The award was issued on September 22, 2025, with performance taking place at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $51,662.58 on August 13, 2025, for the supply of Ofev 100 mg capsules (60-count units). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by September 4, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ofev 100 mg capsules (60-count units) with a ceiling value of $17,260.58. This firm fixed-price delivery order, which is expected to be completed by September 2, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Ofev (nintedanib) is a medication...
- The Defense Logistics Agency awarded a delivery order valued at $17,260.58 to AmerisourceBergen Drug Corp for 60-count bottles of Ofev 100 mg capsules on September 17, 2025, with an ultimate completion date of October 8, 2025. This non-set-aside, firm fixed-price contract represents a competitive award to the pharmaceutical distributor and represents medical supply procurement for federal healthcare needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $17,181.16 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Ofev (nintedanib) 150 mg capsules in a quantity of 60 units. This is a firm fixed price, non-set-aside contract with performance at the awardee's Conshohocken, Pennsylvania location and an ultimate completion date of October 8, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a $17,260.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 capsules of Ofev 100 mg, a pharmaceutical product. The award was made on September 19, 2025, with an ultimate completion date of October 10, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery order from its corporate office location. This delivery order is issued under...
- SPE2DB25D3008Indefinite Delivery Contract
- SPE2DB25D3008-SPE2DB25FRDJMDelivery Order
The Defense Logistics Agency awarded a $17,260.58 delivery order to AmerisourceBergen Drug Corp for 60 capsules of Ofev 100 mg, a pharmaceutical product used in the treatment of idiopathic pulmonary fibrosis. The contract was competitively awarded without set-aside provisions on September 24, 2025, with an ultimate completion date of October 16, 2025. This delivery order operates under a firm fixed-price arrangement and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive pharmaceutical supply vehicle enabling the contractor to provide a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen's extensive federal contract portfolio demonstrates the company's capacity to fulfill complex medical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.3k | 9/24/25 |